Pneumonia. Pneumonia, unspecified
Conditions
Interventions
Intervention 1: Intervention group: oral zinc (zinc sulfate syrup by mouth or gavage) of 20 mg daily for children 12 months and more and 10 mg daily for children less than 12 months, for 7 days. Inter
Treatment - Drugs
Intervention group: oral zinc (zinc sulfate syrup by mouth or gavage) of 20 mg daily for children 12 months and more and 10 mg daily for children less than 12 months, for 7 days
Control group: Placebo
Sponsors
Guilan University of Medical Sciences- Vice Chancellor for Research
Eligibility
Sex/Gender
All
Age
No minimum to 5 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: children 2 months to 5 years old hospitalized in 17 Shahrivar Hospital of Rasht - Iran with fever (axillary temperature 37.5° C or more) and cough and tachypnea or rales. Exclusion criteria: the history of pulmonary disease including asthma, documented heart disease or other chronic disease or immunodeficiency, proven pathologic gastroesophageal reflux disorder, malnutrition or growth failure, and treatment with zinc or a zinc supplement within 3 months past.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever subsidence. Timepoint: Daily during hospitalization. Method of measurement: Degrees Centigrade (axillary method with a mercury thermometer).;Normalization of patient's respiratory rate. Timepoint: Daily during hospitalization. Method of measurement: The number of breaths per minute (patient observation by pediatric resident). | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital discharge or death. Timepoint: Daily during hospitalization. Method of measurement: By pediatric resident. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Houman Hashemian
Guilan University of Medical Sciences
Outcome results
None listed